[
  {
    "title": "TransEnterix beats The Street in Q3 - Mass Device",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "TransEnterix beats The Street in Q3 - Mass Device"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.massdevice.com/transenterix-beats-the-street-in-q3/"
      }
    ],
    "link": "https://www.massdevice.com/transenterix-beats-the-street-in-q3/",
    "id": "CBMiP2h0dHBzOi8vd3d3Lm1hc3NkZXZpY2UuY29tL3RyYW5zZW50ZXJpeC1iZWF0cy10aGUtc3RyZWV0LWluLXEzL9IBAA",
    "guidislink": false,
    "published": "Tue, 10 Nov 2020 16:26:30 GMT",
    "published_parsed": [
      2020,
      11,
      10,
      16,
      26,
      30,
      1,
      315,
      0
    ],
    "summary": "<a href=\"https://www.massdevice.com/transenterix-beats-the-street-in-q3/\" target=\"_blank\">TransEnterix beats The Street in Q3</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Mass Device</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.massdevice.com/transenterix-beats-the-street-in-q3/\" target=\"_blank\">TransEnterix beats The Street in Q3</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Mass Device</font>"
    },
    "source": {
      "href": "https://www.massdevice.com",
      "title": "Mass Device"
    },
    "sub_articles": []
  },
  {
    "title": "FDA clears PTSD nightmare-reduction app - Mass Device",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "FDA clears PTSD nightmare-reduction app - Mass Device"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.massdevice.com/fda-clears-ptsd-nightmare-reduction-app/"
      }
    ],
    "link": "https://www.massdevice.com/fda-clears-ptsd-nightmare-reduction-app/",
    "id": "CBMiQ2h0dHBzOi8vd3d3Lm1hc3NkZXZpY2UuY29tL2ZkYS1jbGVhcnMtcHRzZC1uaWdodG1hcmUtcmVkdWN0aW9uLWFwcC_SAQA",
    "guidislink": false,
    "published": "Tue, 10 Nov 2020 16:13:30 GMT",
    "published_parsed": [
      2020,
      11,
      10,
      16,
      13,
      30,
      1,
      315,
      0
    ],
    "summary": "<a href=\"https://www.massdevice.com/fda-clears-ptsd-nightmare-reduction-app/\" target=\"_blank\">FDA clears PTSD nightmare-reduction app</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Mass Device</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.massdevice.com/fda-clears-ptsd-nightmare-reduction-app/\" target=\"_blank\">FDA clears PTSD nightmare-reduction app</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Mass Device</font>"
    },
    "source": {
      "href": "https://www.massdevice.com",
      "title": "Mass Device"
    },
    "sub_articles": []
  },
  {
    "title": "Pacific Biosciences of California, Inc. (NASDAQ:PACB) is up 188.91% year-to-date, analysts forecast major price rally - Stocks Register",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Pacific Biosciences of California, Inc. (NASDAQ:PACB) is up 188.91% year-to-date, analysts forecast major price rally - Stocks Register"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://stocksregister.com/2020/11/10/pacific-biosciences-of-california-inc-nasdaqpacb-is-up-188-91-year-to-date-analysts-forecast-major-price-rally/"
      }
    ],
    "link": "https://stocksregister.com/2020/11/10/pacific-biosciences-of-california-inc-nasdaqpacb-is-up-188-91-year-to-date-analysts-forecast-major-price-rally/",
    "id": "CBMilQFodHRwczovL3N0b2Nrc3JlZ2lzdGVyLmNvbS8yMDIwLzExLzEwL3BhY2lmaWMtYmlvc2NpZW5jZXMtb2YtY2FsaWZvcm5pYS1pbmMtbmFzZGFxcGFjYi1pcy11cC0xODgtOTEteWVhci10by1kYXRlLWFuYWx5c3RzLWZvcmVjYXN0LW1ham9yLXByaWNlLXJhbGx5L9IBmQFodHRwczovL3N0b2Nrc3JlZ2lzdGVyLmNvbS8yMDIwLzExLzEwL3BhY2lmaWMtYmlvc2NpZW5jZXMtb2YtY2FsaWZvcm5pYS1pbmMtbmFzZGFxcGFjYi1pcy11cC0xODgtOTEteWVhci10by1kYXRlLWFuYWx5c3RzLWZvcmVjYXN0LW1ham9yLXByaWNlLXJhbGx5L2FtcC8",
    "guidislink": false,
    "published": "Tue, 10 Nov 2020 16:00:05 GMT",
    "published_parsed": [
      2020,
      11,
      10,
      16,
      0,
      5,
      1,
      315,
      0
    ],
    "summary": "<a href=\"https://stocksregister.com/2020/11/10/pacific-biosciences-of-california-inc-nasdaqpacb-is-up-188-91-year-to-date-analysts-forecast-major-price-rally/\" target=\"_blank\">Pacific Biosciences of California, Inc. (NASDAQ:PACB) is up 188.91% year-to-date, analysts forecast major price rally</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Stocks Register</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://stocksregister.com/2020/11/10/pacific-biosciences-of-california-inc-nasdaqpacb-is-up-188-91-year-to-date-analysts-forecast-major-price-rally/\" target=\"_blank\">Pacific Biosciences of California, Inc. (NASDAQ:PACB) is up 188.91% year-to-date, analysts forecast major price rally</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Stocks Register</font>"
    },
    "source": {
      "href": "https://stocksregister.com",
      "title": "Stocks Register"
    },
    "sub_articles": []
  },
  {
    "title": "I-MED Pharma launches tearcheck\u00ae in Canada - A new standard in dry eye analysis - Global Banking And Finance Review",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "I-MED Pharma launches tearcheck\u00ae in Canada - A new standard in dry eye analysis - Global Banking And Finance Review"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.globalbankingandfinance.com/category/news/i-med-pharma-launches-tearcheck-in-canada-a-new-standard-in-dry-eye-analysis/"
      }
    ],
    "link": "https://www.globalbankingandfinance.com/category/news/i-med-pharma-launches-tearcheck-in-canada-a-new-standard-in-dry-eye-analysis/",
    "id": "CBMigwFodHRwczovL3d3dy5nbG9iYWxiYW5raW5nYW5kZmluYW5jZS5jb20vY2F0ZWdvcnkvbmV3cy9pLW1lZC1waGFybWEtbGF1bmNoZXMtdGVhcmNoZWNrLWluLWNhbmFkYS1hLW5ldy1zdGFuZGFyZC1pbi1kcnktZXllLWFuYWx5c2lzL9IBgwFodHRwczovL3d3dy5nbG9iYWxiYW5raW5nYW5kZmluYW5jZS5jb20vY2F0ZWdvcnkvbmV3cy9pLW1lZC1waGFybWEtbGF1bmNoZXMtdGVhcmNoZWNrLWluLWNhbmFkYS1hLW5ldy1zdGFuZGFyZC1pbi1kcnktZXllLWFuYWx5c2lzLw",
    "guidislink": false,
    "published": "Tue, 10 Nov 2020 16:25:44 GMT",
    "published_parsed": [
      2020,
      11,
      10,
      16,
      25,
      44,
      1,
      315,
      0
    ],
    "summary": "<a href=\"https://www.globalbankingandfinance.com/category/news/i-med-pharma-launches-tearcheck-in-canada-a-new-standard-in-dry-eye-analysis/\" target=\"_blank\">I-MED Pharma launches tearcheck\u00ae in Canada - A new standard in dry eye analysis</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Global Banking And Finance Review</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.globalbankingandfinance.com/category/news/i-med-pharma-launches-tearcheck-in-canada-a-new-standard-in-dry-eye-analysis/\" target=\"_blank\">I-MED Pharma launches tearcheck\u00ae in Canada - A new standard in dry eye analysis</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Global Banking And Finance Review</font>"
    },
    "source": {
      "href": "https://www.globalbankingandfinance.com",
      "title": "Global Banking And Finance Review"
    },
    "sub_articles": []
  }
]